Primary Job Title President , CEO & Co-Founder, Board Members Primary Organization 
DVS Sciences
Gender Male
Investor Type Investor Stage
Dr. Tanner is based in the Canadian operations located in Toronto, Ontario and provides the focus on research and development of the mass cytometry technology platform at DVS Sciences. A co-founder of DVS, he led the company through the introduction of the company's first products into the marketplace, including the CyTOF® instrument platform
and the MaxPar® reagents line.
Dr. Tanner retains a faculty appointment at the University of Toronto, managing an international collaboration to advance the mass cytometry technology.
Prior to the establishment of DVS in 2004, Dr. Tanner was Principal Scientist with MDS Sciex, the analytical technologies division of MDS Inc. In his 25 years at Sciex, Dr. Tanner developed and helped to commercialize a string of mass spectrometry products.
Dr. Tanner received the 2011 University of Toronto Inventor of the Year Award for Biomedical and Life Sciences, the 2011 ThermoFisher Scientific Spectroscopy Award, the 2003 W.A.E. McBryde medal from the Canadian Chemical Society, and the 2001 Manning Innovation Foundation Award of Distinction.
Dr. Tanner completed his PhD in Physical Chemistry at York University in Toronto. Dr. Tanner is also a Director of DVS.
